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1. Introduction 
The structure of the active site of myosin is being 
intensively investigated [ 1 ] . These studies have some 
bearing on the mechanism of energy conversion (from 
chemical to mechanical), which is performed by the 
contractile proteins in muscle. We have recently shown 
that myosin could be affinity labeled by the complex 
Co(III)-(phen)-ATP [2]. The same complex was 
found useful also in the labeling of other ATPases, such 
as for example, chloroplasts coupling factor 1 [3]. 
Various Co(II1) complexes were previously used in 
other systems [4,5] and inert Co(II1) complexes 
formed by HzOz oxidation of the parent labile Co(I1) 
complexes were successfully employed as affinity 
labels in nucleic acids [6] or enzymes, e.g., asparto- 
kinase [7]. We now show that myosin can also be 
affinity labeled by the in situ oxidation product of 
Co(II)-ATP. 
The structure of the previously used affinity label 
Co(III)-(phen)-ATP, has now been determined and 
shown to contain the labile superoxide ion [8]. It was 
interesting to see if its replacement in the complex by 
the inert cyanide ion would impair its efficiency as an 
affinity label. We report now results on the labeling 
and inhibitory abilities of this and 2 other Co(II1) 
complexes. 
2. Materials and methods 
2.1. Myosin 
Myosin was obtained from the back muscles of 
New Zealand rabbits and stored in 50% glycerol. 
Deglycerination was performed by dialysis against 
0.6 M KCl-containing 5 mM phosphate buffer, pH 7.0 
and the solution was freed from aggregates by 75 min 
centrifugation at 33 000 rev./mm. The specific Ca- 
ATPase activity of the material thus obtained was 
between 0.6 and 0.7 pmol phosphate min-’ . mg-’ 
protein. The ATPase activity was determined in a pH- 
stat at pH 7.6 as previously described [2] 
2.2. Cobaltic complexes 
The cobaltic complexes were prepared by HzOz 
oxidation of Co(I1) in the presence of the various 
ligands, i.e., O-phenanthroline (phen), ATP and cyanide 
ion at a concentration of 10 mM [9]. In the case of 
Co(III)-(phen) and Co(III)-(phen),, the complexes 
could not be precipitated by ethanol at -20°C and 
they were therefore crude mixtures, whereas Co(III)- 
(phen)-ATP-(CN-) was purified as previously 
described [2,9]. 
2.3. Labeling and inhibition 
The in situ-labeling of myosin was performed at 
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0°C with 1 mM Co(II)-ATP, and with 1 mM Mg(II)- 
ATP in the control experiments, in the presence of 
several concentrations of Hz0 at pH 7.0 (5 mM phos- 
phate buffer). Inhibition of myosin Ca-ATPase by 
the various complexes was studied at 2.5 mM ATP 
at several inhibitor concentrations. 
3. Results 
3.1. Labeling of myosin by oxidation of Co(II)-ATP 
in situ using Hz02 
The time-course of myosin labeling with a Co(III)- 
ATP complex formed in situ by oxidation with Hz02 
at low and high ionic strengths is shown in fig.1. It is 
also seen that addition of dithiothreitol (DTT) to the 
Co(III)-ATP-labeled enzyme restored the ATPase 
activity to the level of the control (myosin which 
has been treated with the same HZOz concentration 
in the presence of Mg(II)-ATP). Both the labeling 
and the control reactions (not shown) were much 
faster at low ionic strength. In order to maintain a 
good activity of the control, it was therefore found 
preferable to work at high ionic strength. Figure 2 








Fig.1. Time-course of myosin labeling with in situ-oxidized 
Co(III)-ATP. Myosin (4 mg/ml) was incubated at 0°C in the 
presence of either Mg(II)-ATP or COW)-ATP and three- or 
four-fold molar excess of H,O,. (o-o) Mg (II)-ATP (control), 
ionic strength - 0.60 M, (@-a) Co(II)-ATP, ionic strength - 
0.60 M, (0-o) Co(H)-ATP, ionic strength - 0.15 M. Reac- 
tivation was achieved after 15 min incubation with 50 mM 
DTT at 0°C. 
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Fig.2. Time-course of myosin labeling with in situ-oxidized 
Co(III)-ATP at low H,O, concentrations. Conditions as in 
fig.1, except that [H,O,]/[Co(II)] = 0.7. Ionic strength - 
0.60 M. (o-o) Mg(II)-ATP.(control), (Q-Q) Co(H)-ATP. 
a 5fold lower concentration of H202 than that used 
in fig.1. A biphasic labeling pattern is clearly observed 
in this experiment and is also apparent at the higher 
HzOz concentration at both ionic strengths (fig. 1). 
The rate constants for the inactivation reactions in the 
presence of the Co(III) complex - second phase of 
the labeling pattern - are summarized in table 1 and 
compared with the rate constants of the control 
reactions. 
3.2. Irreversible inhibition of myosin by pre-synthesizec 
Co(III) complexes 
We attempted to inactivate myosin with various 
Co(III) complexes: Co(III)-phen, Co(III)-(phen), 
and Co(U)-(phen)-ATP-(CN-). Whereas we had 
previously observed [2] that 2 mM of Co(III)-(phen) 
ATP-(01) caused 90% inactivation of myosin Ca- 
ATPase in 3 h, there was hardly (<5%) any change 
Table 1 
Rate constants of inactivation of myosin by ‘direct’ affinity 
labeling with Co’+, ATP and H,O, 
Ionic strength (M) 0.15 0.60 0.60 
103 X [H,O,] (M) 3.1 0.8 4.0 
kH,o, (M-’ s-l) 0.054 0.020 0.012 
lo4 x kc,,, (s-l) 3.68 0.57 2.58 
kCo(III)-ATP (M-’ s-‘) 0.295 0.070 0.258 
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Co(III)-(phen) Co(IH)-(phcn,) Co(lIl)-(phen)-ATP-(CN-) Co(llI)-(phen)-ATP-(O;)b 
7 14 ,c 1.5 
Concentration (PM) 
causing 485 490 82 130 
50% inhibitiond 
aIn ‘labeling’ experiments with 2 mM of Co(II1) complex 
bFrom ref. [ 1 ] 
c Less than 5% change in 24 h 
dCa-ATPase activity, using 2.5 mM ATP 
with Co(III)-(phen)3 or Co(III)-(phen)-ATP-(CN-) 
during the same period (with the latter no change 
occurred even after 24 h). On the other hand, 30% 
of the Ca-ATPase activity was lost after 3 h incubation 
of myosin in the presence of 2 mM Co(III)-(phen). 
The half-lifetimes of inactivation of myosin by these 
Co(II1) complexes are summarized in table 2. 
Inhibition experiments using various concentrations 
of complexes in the assay medium for Ca-ATPase 
activity, showed that all Co(II1) complexes tested in 
this and in a previous work [2] were rather good 
inhibitors. However, in all cases parabolic inhibitory 
patterns of l/v versus [complex] were obtained (cf. 
ref. [2]). Therefore, only apparent inhibition con- 
stants - concentrations of Co(II1) complex causing 
50% inhibition - could be calculated (table 2). 
4. Discussion 
It is clearly shown in this work that the active site 
of myosin can be labeled by direct formation of the 
Co(III)-ATP complex in the active site of myosin. 
This sitedirecting effect is due to the fact that 
Co(III)-ATP most probably binds to myosin at the 
same site as Mg(II)-ATP. This is supported by the 
fact that Co(II)-ADP and Mg(II)-ADP have similar 
dissociation constants from heavy meromyosin [lo] . 
The difficulty in this type of labeling is to find con- 
ditions under which the inactivation by Hz02 itself 
is reduced to a minimum. This seems to be the case 
at high ionic strength where the rate of inactivation 
by the Co(II1) complex is 20-fold higher than that 
by H202 (table 1). 
Two important features in these experiments, 
imply that the labeling occurs at the same site as with 
Co(III)-(phen)-ATP-(0;) [2] : 
(i) The biphasic labeling pattern, first enhancement 
of activity, then inactivation. 
(ii) The reactivation by DTT. 
These similarities in the labeling features, obtained 
by two different techniques, provide additional 
evidence for the anti-cooperative behavior of myosin 
active sites [2]. 
The inability of Co(III)-(phen)-ATP-(CN-) to 
inactivate myosin in an irreversible manner definitively 
shows that in order to obtain affinity labeling, one of 
the ligands of the complex has to be rather easily 
exchangeable (by a protein ligand), such as 0; in 
Co(III)-(phen)-ATP-(0;) [2,3,9]. Since neither 
ATP, phenanthroline nor CN- can be exchanged, this 
complex cannot serve as an affinity label, although it 
is a good inhibitor (table 2). That CN- is not exchanged 
is not surprising, since it forms with many metal ions, 
stable and inert complexes [ 111. Moreover, we have 
also been able to make use of this property (that CN- 
is a more stable ligand of Co(II1) than 0,) in order to 
displace 0; from Co(III)-(phen)-ATP-(0;) [8]. 
On the other hand, Co(III)-(phen), whose detailed 
structure was not determined, probably possesses at 
least one exchangeable ligand, possibly a superoxide 
ion, which enables it to attach itself to the protein. 
It does so, however, much more slowly than the ATP- 
containing complex, Co(III)-(phen)-ATP-(0;) and 
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without a phase of activity enhancement. It is note- 
worthy that Co(III)-(phen)s, is a much less potent 
inactivating reagent, probably because the cobaltic ion 
is surrounded by 3 non-exchangeable bidentate ligands. 
It is also possible that the inactivation mechanism 
operating in this case involves oxidation of the 
sulfhydryl groups of myosin, in a manner similar to 
that proposed for the Cu(II)-(phen), complex in 
another system [12] . However, it seems that this 
mechanism does not play an important role in the 
case of ATP-containing Co(II1) complexes since 
Co(III)-(phen)-ATP-(CN-), for instance, cannot 
cause irreversible inactivation at all. 
It may therefore be that Co(II)-(phen) and 
Co(III)-(phen), are directed towards another site 
than that labeled by the presynthesized and in situ- 
oxidized Co(III)-ATP complexes. 
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